ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » West Virginia » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in West Virginia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KATJA FELSINGER M.D.

Endocrinology, Diabetes Metabolism

13,520

$1.81M

505
303 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 48%

$134
Average prescription price

Avg: $139

SAMAR SANKARI MD

Endocrinology, Diabetes Metabolism

8,149

$1.12M

605
322 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 48%

$138
Average prescription price

Avg: $139

ABDUL MIRZA M.D.

Endocrinology, Diabetes Metabolism

7,297

$384K

534
255 are 65+

8%
patients receiving schedule two controlled substances

Avg: 0%

23%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 48%

$53
Average prescription price

Avg: $139

CARLOS JIMENEZ M.D

Endocrinology, Diabetes Metabolism

7,242

$507K

282
233 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 48%

$70
Average prescription price

Avg: $139

SYED HAQ MD

Endocrinology, Diabetes Metabolism

6,319

$807K

420
272 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 48%

$128
Average prescription price

Avg: $139

JULIE BUNNER MD

Endocrinology, Diabetes Metabolism

5,849

$751K

562
431 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 48%

$128
Average prescription price

Avg: $139

ZIAD KAHWASH MD

Endocrinology, Diabetes Metabolism

5,707

$772K

436
318 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 48%

$135
Average prescription price

Avg: $139

SYED RASHEED M.D.

Endocrinology, Diabetes Metabolism

5,473

$541K

255
150 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 48%

$99
Average prescription price

Avg: $139

VIORICA CRISAN MD

Endocrinology, Diabetes Metabolism

5,415

$789K

536
404 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 48%

$146
Average prescription price

Avg: $139

PRASUNA JAMI M.D.

Endocrinology, Diabetes Metabolism

4,925

$643K

518
315 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 48%

$131
Average prescription price

Avg: $139

DANIEL MACIAS MD

Endocrinology, Diabetes Metabolism

4,861

$1.04M

508
368 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

57%
prescriptions for brand name drugs

Avg: 48%

$213
Average prescription price

Avg: $139

ASHRAF MENA MD

Endocrinology, Diabetes Metabolism

4,111

$184K

163
104 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 48%

$45
Average prescription price

Avg: $139

GRETA GUYER MD

Endocrinology, Diabetes Metabolism

3,874

$660K

321
206 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 48%

$170
Average prescription price

Avg: $139

PRASANNA SANTHANAM MD

Endocrinology, Diabetes Metabolism

3,373

$510K

289
150 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 48%

$151
Average prescription price

Avg: $139

RAGHDA SAHLOUL MD

Endocrinology, Diabetes Metabolism

3,172

$685K

284
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

58%
prescriptions for brand name drugs

Avg: 48%

$216
Average prescription price

Avg: $139

PHILIP RYAN MD

Endocrinology, Diabetes Metabolism

3,058

$608K

234
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

56%
prescriptions for brand name drugs

Avg: 48%

$199
Average prescription price

Avg: $139

AYMAN ELKADRY MD

Endocrinology, Diabetes Metabolism

2,830

$458K

234
129 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 48%

$162
Average prescription price

Avg: $139

ARLENE FEDER MD

Endocrinology, Diabetes Metabolism

2,531

$373K

222
154 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 48%

$147
Average prescription price

Avg: $139

JEFFREY SHULTZ MD

Endocrinology, Diabetes Metabolism

2,406

$267K

172
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 48%

$111
Average prescription price

Avg: $139

STEPHEN GRUBB M.D.

Endocrinology, Diabetes Metabolism

2,403

$524K

185
120 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 48%

$218
Average prescription price

Avg: $139

JEREMY SOULE MD

Endocrinology, Diabetes Metabolism

2,346

$372K

293
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 48%

$158
Average prescription price

Avg: $139

FRANK SCHWARTZ M.D.

Endocrinology, Diabetes Metabolism

2,109

$384K

299
230 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 48%

$182
Average prescription price

Avg: $139

LEE ANN SKAFF MD

Endocrinology, Diabetes Metabolism

1,940

$432K

184
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

67%
prescriptions for brand name drugs

Avg: 48%

$223
Average prescription price

Avg: $139

STEVEN ARTZ M.D.

Endocrinology, Diabetes Metabolism

1,861

$212K

218
146 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 48%

$114
Average prescription price

Avg: $139

TIMOTHY JACKSON M. D.

Endocrinology, Diabetes Metabolism

1,848

$356K

312
212 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 48%

$193
Average prescription price

Avg: $139

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank